In the months since the novel coronavirus brought all normal activity to a halt, clinical trials worldwide have been forced to re-examine their strategies and reconsider their approach to data collection, data monitoring, and e-solutions.
TORONTO, Ontario (PRWEB) October 01, 2020
What happens when patients and clinical research associates alike can’t—or won’t—go to your clinical trial sites? It’s time for a new plan. In the months since the novel coronavirus brought all normal activity to a halt, clinical trials worldwide have been forced to re-examine their strategies and reconsider their approach to data collection, data monitoring, and e-solutions. Fortunately, there is a clear path already established: Rare disease trials have dealt with these issues for years.
They have found that mHealth and remote monitoring allow patients the convenience of staying close to home, while still providing clean, concise data. Rare disease trials often combine these and other techniques, enabling much to be accomplished remotely—a structure that may be the future of clinical trials.
Join experts from Premier Research Vicki Gashwiler, Executive Director, Specialty Programs and Anthony Poynton, Director, Program Delivery, Rare Disease & Pediatrics, in a live webinar on Thursday, October 15, 2020 at 11am EDT (4pm BST/UK).
For more information or to register for this event, visit mHealth and Remote Clinical Trial Strategies to Include in Your Next Study.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.